curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

The Effect of Respiratory Muscle Training on Cognitive Performance

by palligoelme@gmail.com | Jun 9, 2026 | Clinical Trials

​ Conditions: Respiratory Muscle Training Interventions: Other: Inspiratory muscle training Sponsors: Indiana University; United States Air Force Research Laboratory Recruiting Conditions: Respiratory Muscle Training Interventions: Other: Inspiratory muscle training...

Effects of a Powered Lower-Limb Exoskeleton on Walking Performance in Older Adults

by palligoelme@gmail.com | Jun 9, 2026 | Clinical Trials

​ Conditions: Aging; Walking; Physical Function; Mobility Limitation Interventions: Device: Powered Lower-Limb Exoskeleton Sponsors: Hunan Normal University Not yet recruiting Conditions: Aging; Walking; Physical Function; Mobility Limitation Interventions: Device:...

Effectiveness of Chinese Herbal Medicine for Older Adults With Urinary Incontinence

by palligoelme@gmail.com | Jun 9, 2026 | Clinical Trials

​ Conditions: Urinary Incontinence (UI) Interventions: Other: Chinese Herbal Medicine (CHM) supplement; Other: Placebo Control Sponsors: Kwantlen Polytechnic University Not yet recruiting Conditions: Urinary Incontinence (UI) Interventions: Other: Chinese Herbal...

The Effect of Action Observation Therapy Including Unimanual and Bimanual Activities in Chronic Stroke

by palligoelme@gmail.com | Jun 9, 2026 | Clinical Trials

​ Conditions: Chronic Stroke Interventions: Other: Action Observation Therapy(unimanuel activities); Other: Action Observation Therapy(bimanuel activities); Other: conventional physiotherapy Sponsors: Karabuk University Recruiting Conditions: Chronic Stroke...

Comparison of Effectiveness and Safety of Tofacitinib Versus Upadacitinib as Add-on to Methotrexate in Rheumatoid Arthritis

by palligoelme@gmail.com | Jun 9, 2026 | Clinical Trials

​ Conditions: Rheumatoid Arthritis (RA) Interventions: Drug: JAK inhibitor(tofacitinib/upadacitinib) as advised by the rheumatologist as add on to 25 mg methotrexate Sponsors: Sheikh Zayed Federal Postgraduate Medical Institute Not yet recruiting Conditions:...

Lomustine Combined With Anlotinib as Interventional Therapy for Extensive-stage Small Cell Lung Cancer Resistant to Second-line and Above Treatment

by palligoelme@gmail.com | Jun 8, 2026 | Clinical Trials

​ Conditions: SCLC, Extensive Stage Interventions: Drug: Lomustine; Drug: Anlotinib Sponsors: Yayi He Not yet recruiting Conditions: SCLC, Extensive Stage Interventions: Drug: Lomustine; Drug: Anlotinib Sponsors: Yayi He Not yet...
« Older Entries
Next Entries »

Recent Posts

  • Resistance Training and Capillarization – Role on the Anabolic Response in Older Adults
  • Effects of a Nurse-Led Self-Compassion and Kindness Program on Compassion and Healthy Peer Relationships in Adolescents
  • Evaluation of an AI-Based Lightweight ECG Telemetry Monitoring System
  • Study Comparing Different Neck Treatment Approaches in Patients With Oral Cancer Without Visible Neck Spread
  • Gamified Cooperative Exergaming Program in Primary School Physical Education

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®